医学
氯吡格雷
传统PCI
经皮冠状动脉介入治疗
阿司匹林
内科学
危险系数
心肌梗塞
急性冠脉综合征
心脏病学
噻氯匹定
支架
置信区间
作者
Jeehoon Kang,Jaewook Chung,Kyung Woo Park,Jang‐Whan Bae,H. K. Lee,Doyeon Hwang,Han‐Mo Yang,Kyoo‐Rok Han,Keon‐Woong Moon,Ung Kim,Moo‐Yong Rhee,Doo‐Il Kim,Song‐Yi Kim,Sung Yun Lee,Seung Uk Lee,Sang‐Hyun Kim,Seok Yeon Kim,Jung‐Kyu Han,Eun–Seok Shin,Bon-Kwon Koo
标识
DOI:10.1001/jamacardio.2024.4030
摘要
Antiplatelet monotherapy in the chronic maintenance period for patients with high bleeding risk (HBR) and those who have undergone complex percutaneous coronary intervention (PCI) has not yet been explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI